

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endothelium development (GO:0003158) | 4.70956480 |
| 2 | lymph vessel development (GO:0001945) | 4.59533367 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 4.43796037 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 4.21820540 |
| 5 | microglial cell activation (GO:0001774) | 4.17016106 |
| 6 | glomerular visceral epithelial cell development (GO:0072015) | 4.12958448 |
| 7 | glomerulus development (GO:0032835) | 4.08192505 |
| 8 | positive regulation of chemokine secretion (GO:0090197) | 4.05017773 |
| 9 | response to peptidoglycan (GO:0032494) | 4.02792630 |
| 10 | positive regulation of mast cell activation (GO:0033005) | 3.93200826 |
| 11 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.90622358 |
| 12 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.84469634 |
| 13 | positive regulation of mast cell degranulation (GO:0043306) | 3.84469634 |
| 14 | detection of molecule of bacterial origin (GO:0032490) | 3.82756045 |
| 15 | surfactant homeostasis (GO:0043129) | 3.76208625 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.68329998 |
| 17 | regulation of chemokine secretion (GO:0090196) | 3.64398009 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.62938276 |
| 19 | glomerular epithelial cell development (GO:0072310) | 3.62072225 |
| 20 | skeletal muscle adaptation (GO:0043501) | 3.53622695 |
| 21 | regulation of germinal center formation (GO:0002634) | 3.51738596 |
| 22 | oligosaccharide catabolic process (GO:0009313) | 3.44364822 |
| 23 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.42890390 |
| 24 | tyrosine metabolic process (GO:0006570) | 3.42455945 |
| 25 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.37046668 |
| 26 | monocyte differentiation (GO:0030224) | 3.29364720 |
| 27 | regulation of mast cell activation (GO:0033003) | 3.28500008 |
| 28 | histamine secretion (GO:0001821) | 3.26423333 |
| 29 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.24458392 |
| 30 | negative regulation of interleukin-12 production (GO:0032695) | 3.24344687 |
| 31 | pigment cell differentiation (GO:0050931) | 3.17802764 |
| 32 | establishment of endothelial barrier (GO:0061028) | 3.11265307 |
| 33 | actin-myosin filament sliding (GO:0033275) | 3.08838849 |
| 34 | muscle filament sliding (GO:0030049) | 3.08838849 |
| 35 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.08466088 |
| 36 | negative regulation of bone resorption (GO:0045779) | 3.06731078 |
| 37 | tryptophan catabolic process (GO:0006569) | 3.05670690 |
| 38 | indole-containing compound catabolic process (GO:0042436) | 3.05670690 |
| 39 | indolalkylamine catabolic process (GO:0046218) | 3.05670690 |
| 40 | positive regulation of vasculogenesis (GO:2001214) | 3.00048725 |
| 41 | melanin metabolic process (GO:0006582) | 2.99487034 |
| 42 | macrophage activation (GO:0042116) | 2.97784737 |
| 43 | glomerular basement membrane development (GO:0032836) | 2.97710361 |
| 44 | regulation of mast cell degranulation (GO:0043304) | 2.97568370 |
| 45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.97028863 |
| 46 | actin-mediated cell contraction (GO:0070252) | 2.95780073 |
| 47 | regulation of T cell tolerance induction (GO:0002664) | 2.95529553 |
| 48 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.94349675 |
| 49 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.94144207 |
| 50 | melanin biosynthetic process (GO:0042438) | 2.93161541 |
| 51 | melanocyte differentiation (GO:0030318) | 2.92590595 |
| 52 | skeletal muscle contraction (GO:0003009) | 2.91402144 |
| 53 | sodium-independent organic anion transport (GO:0043252) | 2.89745518 |
| 54 | keratan sulfate catabolic process (GO:0042340) | 2.87856178 |
| 55 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.87731387 |
| 56 | detection of external biotic stimulus (GO:0098581) | 2.87629183 |
| 57 | cellular response to ethanol (GO:0071361) | 2.87451282 |
| 58 | myeloid cell activation involved in immune response (GO:0002275) | 2.86849415 |
| 59 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.86437166 |
| 60 | neutrophil activation (GO:0042119) | 2.86224985 |
| 61 | definitive hemopoiesis (GO:0060216) | 2.86089742 |
| 62 | granulocyte activation (GO:0036230) | 2.86075648 |
| 63 | cellular extravasation (GO:0045123) | 2.85901166 |
| 64 | cGMP-mediated signaling (GO:0019934) | 2.85570142 |
| 65 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.82073351 |
| 66 | positive regulation of leukocyte degranulation (GO:0043302) | 2.80813792 |
| 67 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.79233391 |
| 68 | aromatic amino acid family catabolic process (GO:0009074) | 2.77777331 |
| 69 | immunoglobulin mediated immune response (GO:0016064) | 2.76597446 |
| 70 | positive regulation of respiratory burst (GO:0060267) | 2.76191127 |
| 71 | chemical homeostasis within a tissue (GO:0048875) | 2.74645412 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 2.74170001 |
| 73 | amine catabolic process (GO:0009310) | 2.74170001 |
| 74 | hepatocyte apoptotic process (GO:0097284) | 2.73196077 |
| 75 | macrophage activation involved in immune response (GO:0002281) | 2.73097188 |
| 76 | platelet dense granule organization (GO:0060155) | 2.70141723 |
| 77 | secondary metabolite biosynthetic process (GO:0044550) | 2.69878868 |
| 78 | germinal center formation (GO:0002467) | 2.69556859 |
| 79 | phospholipid homeostasis (GO:0055091) | 2.68307294 |
| 80 | iron ion import (GO:0097286) | 2.67245320 |
| 81 | T-helper 1 type immune response (GO:0042088) | 2.65313489 |
| 82 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.65215310 |
| 83 | regulation of vasculogenesis (GO:2001212) | 2.64812352 |
| 84 | tryptophan metabolic process (GO:0006568) | 2.63118355 |
| 85 | regulation of hypersensitivity (GO:0002883) | 2.62913066 |
| 86 | histamine transport (GO:0051608) | 2.61825515 |
| 87 | negative regulation of platelet activation (GO:0010544) | 2.59147273 |
| 88 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.58929901 |
| 89 | monocyte chemotaxis (GO:0002548) | 2.58701864 |
| 90 | sprouting angiogenesis (GO:0002040) | 2.58124378 |
| 91 | positive regulation of interferon-alpha production (GO:0032727) | 2.57867509 |
| 92 | striated muscle atrophy (GO:0014891) | 2.56008699 |
| 93 | N-acetylneuraminate metabolic process (GO:0006054) | 2.55389017 |
| 94 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.55079165 |
| 95 | aromatic amino acid family metabolic process (GO:0009072) | 2.54180419 |
| 96 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.53556547 |
| 97 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.53215592 |
| 98 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.51252381 |
| 99 | detection of biotic stimulus (GO:0009595) | 2.50520430 |
| 100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.49733168 |
| 101 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.49355759 |
| 102 | intracellular pH reduction (GO:0051452) | 2.47654477 |
| 103 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.46749426 |
| 104 | detection of other organism (GO:0098543) | 2.46469114 |
| 105 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.46397301 |
| 106 | L-phenylalanine catabolic process (GO:0006559) | 2.46397301 |
| 107 | positive regulation by symbiont of host defense response (GO:0052509) | 2.46367594 |
| 108 | modulation by symbiont of host defense response (GO:0052031) | 2.46367594 |
| 109 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.46367594 |
| 110 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.46367594 |
| 111 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.46367594 |
| 112 | modulation by symbiont of host immune response (GO:0052553) | 2.46367594 |
| 113 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.46022978 |
| 114 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.44877779 |
| 115 | response to muscle activity (GO:0014850) | 2.44318015 |
| 116 | regulation of interferon-alpha production (GO:0032647) | 2.44306924 |
| 117 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.44171555 |
| 118 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.44118564 |
| 119 | actin filament-based movement (GO:0030048) | 2.43520428 |
| 120 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.43389797 |
| 121 | phagosome maturation (GO:0090382) | 2.43311832 |
| 122 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.43097916 |
| 123 | xenobiotic catabolic process (GO:0042178) | 2.42347761 |
| 124 | response to host immune response (GO:0052572) | 2.41354512 |
| 125 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.41354512 |
| 126 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.40182554 |
| 127 | complement activation, alternative pathway (GO:0006957) | 2.39751859 |
| 128 | regulation of endothelial cell differentiation (GO:0045601) | 2.39524679 |
| 129 | neutrophil chemotaxis (GO:0030593) | 2.39434248 |
| 130 | regulation of cell communication by electrical coupling (GO:0010649) | 2.38868672 |
| 131 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.37439630 |
| 132 | low-density lipoprotein particle remodeling (GO:0034374) | 2.37415212 |
| 133 | import into cell (GO:0098657) | 2.36880201 |
| 134 | regulation of relaxation of muscle (GO:1901077) | 2.36227250 |
| 135 | muscle atrophy (GO:0014889) | 2.35819783 |
| 136 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.35748802 |
| 137 | leukocyte tethering or rolling (GO:0050901) | 2.35223045 |
| 138 | kynurenine metabolic process (GO:0070189) | 2.35129149 |
| 139 | negative regulation of granulocyte differentiation (GO:0030853) | 2.34665897 |
| 140 | lysosome organization (GO:0007040) | 2.34343902 |
| 141 | lytic vacuole organization (GO:0080171) | 2.34343902 |
| 142 | neutrophil migration (GO:1990266) | 2.33760168 |
| 143 | mesodermal cell differentiation (GO:0048333) | 2.33556370 |
| 144 | response to methylmercury (GO:0051597) | 2.32980401 |
| 145 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.32769074 |
| 146 | germ cell migration (GO:0008354) | 2.32324728 |
| 147 | neutrophil mediated immunity (GO:0002446) | 2.31963158 |
| 148 | regulation of mononuclear cell migration (GO:0071675) | 2.31256127 |
| 149 | regulation of platelet activation (GO:0010543) | 2.31052473 |
| 150 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.30645209 |
| 151 | defense response to protozoan (GO:0042832) | 2.30458873 |
| 152 | glycolipid catabolic process (GO:0019377) | 2.30436682 |
| 153 | positive regulation of focal adhesion assembly (GO:0051894) | 2.30173209 |
| 154 | positive regulation of cell junction assembly (GO:1901890) | 2.30173209 |
| 155 | transcytosis (GO:0045056) | 2.29637835 |
| 156 | natural killer cell differentiation (GO:0001779) | 2.29598731 |
| 157 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.28723870 |
| 158 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.28673103 |
| 159 | negative regulation of bone remodeling (GO:0046851) | 2.27803004 |
| 160 | lymphangiogenesis (GO:0001946) | 2.27694554 |
| 161 | negative regulation of interleukin-17 production (GO:0032700) | 2.27436218 |
| 162 | negative regulation of mast cell activation (GO:0033004) | 2.27121888 |
| 163 | superoxide anion generation (GO:0042554) | 2.26930783 |
| 164 | patterning of blood vessels (GO:0001569) | 2.26774771 |
| 165 | glycosphingolipid catabolic process (GO:0046479) | 2.26712161 |
| 166 | negative regulation of tissue remodeling (GO:0034104) | 2.26640971 |
| 167 | regulation of leukocyte degranulation (GO:0043300) | 2.26223812 |
| 168 | reverse cholesterol transport (GO:0043691) | 2.26131646 |
| 169 | Notch receptor processing (GO:0007220) | 2.26011270 |
| 170 | negative regulation of protein autophosphorylation (GO:0031953) | 2.24798160 |
| 171 | regulation of platelet aggregation (GO:0090330) | 2.22556490 |
| 172 | negative regulation of muscle contraction (GO:0045932) | 2.20948709 |
| 173 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.20347534 |
| 174 | response to laminar fluid shear stress (GO:0034616) | 2.19365208 |
| 175 | positive regulation of antigen processing and presentation (GO:0002579) | 2.19321676 |
| 176 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.18349472 |
| 177 | blood vessel maturation (GO:0001955) | 2.17090024 |
| 178 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.16890047 |
| 179 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.16276743 |
| 180 | relaxation of cardiac muscle (GO:0055119) | 2.15753247 |
| 181 | substrate-dependent cell migration (GO:0006929) | 2.15464482 |
| 182 | dendritic cell migration (GO:0036336) | 2.14984438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.18226923 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.05763158 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.16347292 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.04783223 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.81622699 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.79709509 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.41813364 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.41239870 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34400539 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.33138291 |
| 11 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.27095876 |
| 12 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.20346330 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.17740820 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.15903839 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.10734767 |
| 16 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.04173060 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.03939520 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00673747 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.00430183 |
| 20 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.99603011 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.93904359 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.92250926 |
| 23 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.90620371 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.90437050 |
| 25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.84858189 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.83950969 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83075498 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.78517683 |
| 29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.69576878 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.69103212 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67758515 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67662114 |
| 33 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.67401323 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.66953014 |
| 35 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.66480356 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64666305 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64241210 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.58539696 |
| 39 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.58479146 |
| 40 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.57268411 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.56736583 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.56690158 |
| 43 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.51115713 |
| 44 | GATA1_19941826_ChIP-Seq_K562_Human | 1.49282050 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.48303030 |
| 46 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.45317489 |
| 47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.41572781 |
| 48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.41387671 |
| 49 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.41094218 |
| 50 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41061179 |
| 51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40513842 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.39999898 |
| 53 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.39969667 |
| 54 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.39619610 |
| 55 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39169526 |
| 56 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38098870 |
| 57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37960063 |
| 58 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37643916 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.37288877 |
| 60 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.36225814 |
| 61 | GATA2_19941826_ChIP-Seq_K562_Human | 1.34724800 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33733184 |
| 63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.30712962 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30251121 |
| 65 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.28205631 |
| 66 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27856027 |
| 67 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26932774 |
| 68 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26186561 |
| 69 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.24169533 |
| 70 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.24169533 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.22923553 |
| 72 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.22497670 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22356055 |
| 74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.22044419 |
| 75 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.21500895 |
| 76 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20921491 |
| 77 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19713655 |
| 78 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.19087848 |
| 79 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.18884887 |
| 80 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17745787 |
| 81 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17687991 |
| 82 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16644678 |
| 83 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.15864538 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15864042 |
| 85 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.15780735 |
| 86 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15211531 |
| 87 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14701493 |
| 88 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14504428 |
| 89 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14241062 |
| 90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12806431 |
| 91 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11519655 |
| 92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10805838 |
| 93 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10659725 |
| 94 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.09561560 |
| 95 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09495586 |
| 96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.09448440 |
| 97 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.09448440 |
| 98 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09368621 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09368621 |
| 100 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08819361 |
| 101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08441273 |
| 102 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08157024 |
| 103 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07707384 |
| 104 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07463534 |
| 105 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.07121342 |
| 106 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.06024158 |
| 107 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05799550 |
| 108 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.05486810 |
| 109 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.05433429 |
| 110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05405975 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05272295 |
| 112 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04900154 |
| 113 | FUS_26573619_Chip-Seq_HEK293_Human | 1.04705089 |
| 114 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04664973 |
| 115 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.03835859 |
| 116 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03438495 |
| 117 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03136230 |
| 118 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03014678 |
| 119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02995062 |
| 120 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01968211 |
| 121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01868574 |
| 122 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01868574 |
| 123 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.01524992 |
| 124 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.01445933 |
| 125 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.01230624 |
| 126 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00722955 |
| 127 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00671323 |
| 128 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.00453264 |
| 129 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00271031 |
| 130 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00154123 |
| 131 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00074729 |
| 132 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99742810 |
| 133 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.99675712 |
| 134 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99113623 |
| 135 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99026391 |
| 136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99026391 |
| 137 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98472625 |
| 138 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98131482 |
| 139 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.96561909 |
| 140 | MYB_26560356_Chip-Seq_TH2_Human | 0.95022258 |
| 141 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94757402 |
| 142 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94558727 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94212314 |
| 144 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90853476 |
| 145 | MAF_26560356_Chip-Seq_TH1_Human | 0.90474808 |
| 146 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90342830 |
| 147 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89900607 |
| 148 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88380187 |
| 149 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87295842 |
| 150 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.83978067 |
| 151 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.83810687 |
| 152 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83436058 |
| 153 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80969249 |
| 154 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80693417 |
| 155 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80601487 |
| 156 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.79881677 |
| 157 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79310590 |
| 158 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78350171 |
| 159 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77810388 |
| 160 | MYB_26560356_Chip-Seq_TH1_Human | 0.77242868 |
| 161 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.76248844 |
| 162 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76226092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 4.41621616 |
| 2 | MP0003195_calcinosis | 3.66971168 |
| 3 | MP0003724_increased_susceptibility_to | 3.63976176 |
| 4 | MP0001879_abnormal_lymphatic_vessel | 3.11541422 |
| 5 | MP0000372_irregular_coat_pigmentation | 3.06874584 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.04033245 |
| 7 | MP0005167_abnormal_blood-brain_barrier | 3.01316471 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.80043268 |
| 9 | MP0010368_abnormal_lymphatic_system | 2.78502593 |
| 10 | MP0005075_abnormal_melanosome_morpholog | 2.72632206 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.60074586 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.59609136 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.58035608 |
| 14 | MP0006082_CNS_inflammation | 2.47826294 |
| 15 | MP0000749_muscle_degeneration | 2.36417972 |
| 16 | MP0000015_abnormal_ear_pigmentation | 2.29828336 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.29080969 |
| 18 | MP0004484_altered_response_of | 2.26660100 |
| 19 | MP0005671_abnormal_response_to | 2.25014991 |
| 20 | MP0003828_pulmonary_edema | 2.23614111 |
| 21 | MP0005171_absent_coat_pigmentation | 2.23289048 |
| 22 | MP0001873_stomach_inflammation | 2.22257404 |
| 23 | MP0003136_yellow_coat_color | 2.19285317 |
| 24 | MP0000371_diluted_coat_color | 2.14582580 |
| 25 | MP0005174_abnormal_tail_pigmentation | 2.09619875 |
| 26 | MP0004510_myositis | 1.98303290 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.98211288 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 1.94910410 |
| 29 | MP0000343_altered_response_to | 1.88272580 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.87249615 |
| 31 | MP0009840_abnormal_foam_cell | 1.85169079 |
| 32 | MP0008004_abnormal_stomach_pH | 1.79841328 |
| 33 | MP0004036_abnormal_muscle_relaxation | 1.77635954 |
| 34 | MP0009278_abnormal_bone_marrow | 1.69355732 |
| 35 | MP0001851_eye_inflammation | 1.66171283 |
| 36 | MP0002095_abnormal_skin_pigmentation | 1.61537291 |
| 37 | MP0004084_abnormal_cardiac_muscle | 1.58864021 |
| 38 | MP0003646_muscle_fatigue | 1.58428322 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.56859720 |
| 40 | MP0005408_hypopigmentation | 1.55154638 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.53632393 |
| 42 | MP0002419_abnormal_innate_immunity | 1.53338104 |
| 43 | MP0001800_abnormal_humoral_immune | 1.51991801 |
| 44 | MP0005165_increased_susceptibility_to | 1.51912458 |
| 45 | MP0001790_abnormal_immune_system | 1.48395992 |
| 46 | MP0005387_immune_system_phenotype | 1.48395992 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.45306840 |
| 48 | MP0002405_respiratory_system_inflammati | 1.42193111 |
| 49 | MP0003045_fibrosis | 1.40895125 |
| 50 | MP0004272_abnormal_basement_membrane | 1.37907217 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.34695971 |
| 52 | MP0002723_abnormal_immune_serum | 1.33032066 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 1.32515024 |
| 54 | MP0002933_joint_inflammation | 1.32179559 |
| 55 | MP0005166_decreased_susceptibility_to | 1.31084218 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.30689298 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.30560857 |
| 58 | MP0005000_abnormal_immune_tolerance | 1.29858695 |
| 59 | MP0001819_abnormal_immune_cell | 1.29373463 |
| 60 | MP0002420_abnormal_adaptive_immunity | 1.28952050 |
| 61 | MP0009785_altered_susceptibility_to | 1.28336443 |
| 62 | MP0005620_abnormal_muscle_contractility | 1.27382658 |
| 63 | MP0005365_abnormal_bile_salt | 1.27353563 |
| 64 | MP0000767_abnormal_smooth_muscle | 1.26025240 |
| 65 | MP0000249_abnormal_blood_vessel | 1.23777618 |
| 66 | MP0000604_amyloidosis | 1.23452416 |
| 67 | MP0003303_peritoneal_inflammation | 1.22681593 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.22652959 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.22652959 |
| 70 | MP0006054_spinal_hemorrhage | 1.22554813 |
| 71 | MP0002090_abnormal_vision | 1.22160257 |
| 72 | MP0000733_abnormal_muscle_development | 1.21851081 |
| 73 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21850800 |
| 74 | MP0003878_abnormal_ear_physiology | 1.20137802 |
| 75 | MP0005377_hearing/vestibular/ear_phenot | 1.20137802 |
| 76 | MP0005025_abnormal_response_to | 1.19992275 |
| 77 | MP0001324_abnormal_eye_pigmentation | 1.19391404 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.18442558 |
| 79 | MP0002332_abnormal_exercise_endurance | 1.16287937 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 1.15645497 |
| 81 | MP0010155_abnormal_intestine_physiology | 1.15113080 |
| 82 | MP0003279_aneurysm | 1.14451928 |
| 83 | MP0002075_abnormal_coat/hair_pigmentati | 1.11130065 |
| 84 | MP0003950_abnormal_plasma_membrane | 1.10346210 |
| 85 | MP0006138_congestive_heart_failure | 1.09786811 |
| 86 | MP0004130_abnormal_muscle_cell | 1.09180032 |
| 87 | MP0004215_abnormal_myocardial_fiber | 1.09163996 |
| 88 | MP0002396_abnormal_hematopoietic_system | 1.09057808 |
| 89 | MP0003075_altered_response_to | 1.09027255 |
| 90 | MP0000685_abnormal_immune_system | 1.08580339 |
| 91 | MP0002972_abnormal_cardiac_muscle | 1.07730160 |
| 92 | MP0004883_abnormal_blood_vessel | 1.05480111 |
| 93 | MP0003943_abnormal_hepatobiliary_system | 1.04787586 |
| 94 | MP0003436_decreased_susceptibility_to | 1.04615302 |
| 95 | MP0003763_abnormal_thymus_physiology | 1.04123352 |
| 96 | MP0009379_abnormal_foot_pigmentation | 1.04030061 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 1.02386905 |
| 98 | MP0002106_abnormal_muscle_physiology | 1.01593486 |
| 99 | MP0001542_abnormal_bone_strength | 0.98893216 |
| 100 | MP0002166_altered_tumor_susceptibility | 0.98868182 |
| 101 | MP0002638_abnormal_pupillary_reflex | 0.98364624 |
| 102 | MP0004381_abnormal_hair_follicle | 0.98361033 |
| 103 | MP0005623_abnormal_meninges_morphology | 0.96705765 |
| 104 | MP0005369_muscle_phenotype | 0.96201537 |
| 105 | MP0009046_muscle_twitch | 0.95966029 |
| 106 | MP0002877_abnormal_melanocyte_morpholog | 0.95749719 |
| 107 | MP0004185_abnormal_adipocyte_glucose | 0.95748878 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.95488748 |
| 109 | MP0009764_decreased_sensitivity_to | 0.94579429 |
| 110 | MP0000920_abnormal_myelination | 0.94537796 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 0.93179555 |
| 112 | MP0003690_abnormal_glial_cell | 0.93128356 |
| 113 | MP0005164_abnormal_response_to | 0.92982671 |
| 114 | MP0001958_emphysema | 0.92809741 |
| 115 | MP0006036_abnormal_mitochondrial_physio | 0.92758281 |
| 116 | MP0000747_muscle_weakness | 0.91341721 |
| 117 | MP0008469_abnormal_protein_level | 0.90272439 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.88486170 |
| 119 | MP0003633_abnormal_nervous_system | 0.87356301 |
| 120 | MP0001186_pigmentation_phenotype | 0.87353148 |
| 121 | MP0009384_cardiac_valve_regurgitation | 0.86712322 |
| 122 | MP0002108_abnormal_muscle_morphology | 0.86572168 |
| 123 | MP0002138_abnormal_hepatobiliary_system | 0.86272240 |
| 124 | MP0004947_skin_inflammation | 0.85891740 |
| 125 | MP0003252_abnormal_bile_duct | 0.85584232 |
| 126 | MP0005379_endocrine/exocrine_gland_phen | 0.85351193 |
| 127 | MP0002128_abnormal_blood_circulation | 0.84045683 |
| 128 | MP0004808_abnormal_hematopoietic_stem | 0.84027472 |
| 129 | MP0000689_abnormal_spleen_morphology | 0.83694186 |
| 130 | MP0002009_preneoplasia | 0.82573223 |
| 131 | MP0005085_abnormal_gallbladder_physiolo | 0.82301123 |
| 132 | MP0000716_abnormal_immune_system | 0.82162193 |
| 133 | MP0005310_abnormal_salivary_gland | 0.81692087 |
| 134 | MP0004782_abnormal_surfactant_physiolog | 0.81219134 |
| 135 | MP0010329_abnormal_lipoprotein_level | 0.79760442 |
| 136 | MP0002693_abnormal_pancreas_physiology | 0.76647181 |
| 137 | MP0004043_abnormal_pH_regulation | 0.75130388 |
| 138 | MP0005253_abnormal_eye_physiology | 0.72587530 |
| 139 | MP0009763_increased_sensitivity_to | 0.70995158 |
| 140 | MP0002118_abnormal_lipid_homeostasis | 0.69840136 |
| 141 | MP0005551_abnormal_eye_electrophysiolog | 0.67401394 |
| 142 | MP0002909_abnormal_adrenal_gland | 0.67166695 |
| 143 | MP0002229_neurodegeneration | 0.66900693 |
| 144 | MP0005535_abnormal_body_temperature | 0.66214467 |
| 145 | MP0005670_abnormal_white_adipose | 0.65218989 |
| 146 | MP0005332_abnormal_amino_acid | 0.64888491 |
| 147 | MP0005451_abnormal_body_composition | 0.63981610 |
| 148 | MP0001853_heart_inflammation | 0.62384923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.74064463 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.74064463 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.74064463 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 4.98161881 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.95338033 |
| 6 | Muscle fiber inclusion bodies (HP:0100299) | 4.44807226 |
| 7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.26691426 |
| 8 | Glomerulonephritis (HP:0000099) | 4.23047235 |
| 9 | Exercise-induced myalgia (HP:0003738) | 4.15558118 |
| 10 | Nemaline bodies (HP:0003798) | 4.10699540 |
| 11 | Ileus (HP:0002595) | 3.73972934 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 3.64192784 |
| 13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.59364871 |
| 14 | Arterial tortuosity (HP:0005116) | 3.54033279 |
| 15 | Congenital, generalized hypertrichosis (HP:0004540) | 3.49504412 |
| 16 | Muscle stiffness (HP:0003552) | 3.48119749 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.37445929 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.36885804 |
| 19 | Hypoplasia of the fovea (HP:0007750) | 3.32037094 |
| 20 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.32037094 |
| 21 | Albinism (HP:0001022) | 3.22304797 |
| 22 | Hematochezia (HP:0002573) | 3.21192471 |
| 23 | Colitis (HP:0002583) | 3.14074960 |
| 24 | Aortic aneurysm (HP:0004942) | 3.10441282 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.09435251 |
| 26 | Vascular tortuosity (HP:0004948) | 3.08116077 |
| 27 | Calf muscle hypertrophy (HP:0008981) | 3.03141805 |
| 28 | Urethral obstruction (HP:0000796) | 3.01925130 |
| 29 | Spontaneous hematomas (HP:0007420) | 3.01663012 |
| 30 | Stomatitis (HP:0010280) | 3.01285843 |
| 31 | Disinhibition (HP:0000734) | 3.00079622 |
| 32 | Round ear (HP:0100830) | 2.91482548 |
| 33 | Blue irides (HP:0000635) | 2.89135257 |
| 34 | Thick nail (HP:0001805) | 2.89037818 |
| 35 | Paralysis (HP:0003470) | 2.88989107 |
| 36 | White forelock (HP:0002211) | 2.84646487 |
| 37 | Ulnar deviation of the wrist (HP:0003049) | 2.84360552 |
| 38 | Recurrent abscess formation (HP:0002722) | 2.82565859 |
| 39 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.79440332 |
| 40 | Abnormality of the fovea (HP:0000493) | 2.78128378 |
| 41 | Polycythemia (HP:0001901) | 2.74225846 |
| 42 | Distal arthrogryposis (HP:0005684) | 2.73421275 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 2.73420952 |
| 44 | Patchy hypopigmentation of hair (HP:0011365) | 2.73325094 |
| 45 | Complement deficiency (HP:0004431) | 2.71854786 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.71070348 |
| 47 | Optic neuritis (HP:0100653) | 2.71070348 |
| 48 | Nephritis (HP:0000123) | 2.68407739 |
| 49 | Mesangial abnormality (HP:0001966) | 2.68284243 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 2.66490553 |
| 51 | Generalized hypopigmentation (HP:0007513) | 2.66275827 |
| 52 | Type 1 muscle fiber predominance (HP:0003803) | 2.59419701 |
| 53 | Eczematoid dermatitis (HP:0000976) | 2.58538502 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.54354626 |
| 55 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.54185443 |
| 56 | Loss of speech (HP:0002371) | 2.54005965 |
| 57 | Agammaglobulinemia (HP:0004432) | 2.53244083 |
| 58 | Myositis (HP:0100614) | 2.51728182 |
| 59 | Muscle fiber splitting (HP:0003555) | 2.49078741 |
| 60 | Ocular albinism (HP:0001107) | 2.47927704 |
| 61 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.46469824 |
| 62 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.46469824 |
| 63 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.46469824 |
| 64 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.46196514 |
| 65 | Nonprogressive disorder (HP:0003680) | 2.45225530 |
| 66 | Recurrent skin infections (HP:0001581) | 2.41703220 |
| 67 | Orchitis (HP:0100796) | 2.41030375 |
| 68 | Chronic diarrhea (HP:0002028) | 2.40816377 |
| 69 | Myoglobinuria (HP:0002913) | 2.39916039 |
| 70 | Mediastinal lymphadenopathy (HP:0100721) | 2.39856915 |
| 71 | Myopathic facies (HP:0002058) | 2.38913402 |
| 72 | Purpura (HP:0000979) | 2.38541547 |
| 73 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.37810907 |
| 74 | Mutism (HP:0002300) | 2.37767015 |
| 75 | Neonatal short-limb short stature (HP:0008921) | 2.37416045 |
| 76 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.34446505 |
| 77 | Hemoptysis (HP:0002105) | 2.29079037 |
| 78 | EMG: myopathic abnormalities (HP:0003458) | 2.28966781 |
| 79 | Myocardial infarction (HP:0001658) | 2.28632765 |
| 80 | Facial diplegia (HP:0001349) | 2.28394441 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.26795999 |
| 82 | Hyperlipoproteinemia (HP:0010980) | 2.24460926 |
| 83 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.23855462 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.23855462 |
| 85 | Petechiae (HP:0000967) | 2.19503608 |
| 86 | Myotonia (HP:0002486) | 2.18823369 |
| 87 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17692377 |
| 88 | Obstructive lung disease (HP:0006536) | 2.17692377 |
| 89 | Hyperkalemia (HP:0002153) | 2.16720248 |
| 90 | Increased CSF protein (HP:0002922) | 2.16445874 |
| 91 | Gingival bleeding (HP:0000225) | 2.15019171 |
| 92 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.14895967 |
| 93 | Autoimmune hemolytic anemia (HP:0001890) | 2.14676168 |
| 94 | Aortic dissection (HP:0002647) | 2.12549839 |
| 95 | Iris hypopigmentation (HP:0007730) | 2.11855344 |
| 96 | IgM deficiency (HP:0002850) | 2.11398691 |
| 97 | Xanthomatosis (HP:0000991) | 2.11310420 |
| 98 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.10795993 |
| 99 | Long clavicles (HP:0000890) | 2.10059052 |
| 100 | Epistaxis (HP:0000421) | 2.09505698 |
| 101 | Hyporeflexia of lower limbs (HP:0002600) | 2.09403406 |
| 102 | Polyneuropathy (HP:0001271) | 2.09016928 |
| 103 | Focal segmental glomerulosclerosis (HP:0000097) | 2.08406331 |
| 104 | Metaphyseal dysplasia (HP:0100255) | 2.07620708 |
| 105 | Absent phalangeal crease (HP:0006109) | 2.07607398 |
| 106 | Abnormality of complement system (HP:0005339) | 2.06940450 |
| 107 | Pulmonary embolism (HP:0002204) | 2.05377772 |
| 108 | Difficulty running (HP:0009046) | 2.04029322 |
| 109 | Ketoacidosis (HP:0001993) | 2.03113622 |
| 110 | Retinal atrophy (HP:0001105) | 2.01864315 |
| 111 | Hypoplastic ischia (HP:0003175) | 2.00198162 |
| 112 | Hypoglycemic coma (HP:0001325) | 1.99233267 |
| 113 | Asymmetric septal hypertrophy (HP:0001670) | 1.97406815 |
| 114 | Abnormality of iron homeostasis (HP:0011031) | 1.97329951 |
| 115 | Epiphyseal dysplasia (HP:0002656) | 1.96704844 |
| 116 | Impaired platelet aggregation (HP:0003540) | 1.96473867 |
| 117 | Abnormal platelet function (HP:0011869) | 1.96473867 |
| 118 | Vacuolated lymphocytes (HP:0001922) | 1.96205792 |
| 119 | Rhabdomyolysis (HP:0003201) | 1.94884341 |
| 120 | Pulmonary infiltrates (HP:0002113) | 1.92987446 |
| 121 | Meningitis (HP:0001287) | 1.92641358 |
| 122 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90877838 |
| 123 | Gangrene (HP:0100758) | 1.90835440 |
| 124 | Hypoglycemic seizures (HP:0002173) | 1.90701957 |
| 125 | Abnormality of the prostate (HP:0008775) | 1.90348803 |
| 126 | Abnormality of the calf musculature (HP:0001430) | 1.90332018 |
| 127 | Inappropriate behavior (HP:0000719) | 1.89556766 |
| 128 | Vasculitis (HP:0002633) | 1.89207192 |
| 129 | Amyloidosis (HP:0011034) | 1.88725171 |
| 130 | Flat capital femoral epiphysis (HP:0003370) | 1.88713058 |
| 131 | Increased connective tissue (HP:0009025) | 1.88319133 |
| 132 | Recurrent bacterial skin infections (HP:0005406) | 1.84537417 |
| 133 | Cerebral palsy (HP:0100021) | 1.83652823 |
| 134 | Arterial thrombosis (HP:0004420) | 1.83128065 |
| 135 | Metaphyseal irregularity (HP:0003025) | 1.82331774 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82049456 |
| 137 | Recurrent fungal infections (HP:0002841) | 1.81525274 |
| 138 | Cerebral aneurysm (HP:0004944) | 1.81048235 |
| 139 | Generalized hypopigmentation of hair (HP:0011358) | 1.81044678 |
| 140 | Prolonged bleeding time (HP:0003010) | 1.80447199 |
| 141 | Ventricular fibrillation (HP:0001663) | 1.79622052 |
| 142 | Conjunctival telangiectasia (HP:0000524) | 1.78979573 |
| 143 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.78796852 |
| 144 | Recurrent cutaneous fungal infections (HP:0011370) | 1.78796852 |
| 145 | Neck muscle weakness (HP:0000467) | 1.78621125 |
| 146 | Bundle branch block (HP:0011710) | 1.78431906 |
| 147 | Abnormality of chloride homeostasis (HP:0011422) | 1.78164769 |
| 148 | Pustule (HP:0200039) | 1.78079787 |
| 149 | Ketosis (HP:0001946) | 1.77308426 |
| 150 | Abnormality of the periventricular white matter (HP:0002518) | 1.76461187 |
| 151 | Congenital sensorineural hearing impairment (HP:0008527) | 1.74741509 |
| 152 | Abnormality of the ischium (HP:0003174) | 1.74677543 |
| 153 | Thyroiditis (HP:0100646) | 1.74125658 |
| 154 | Nuclear cataract (HP:0100018) | 1.73886855 |
| 155 | Tetany (HP:0001281) | 1.73410103 |
| 156 | Hyperactive renin-angiotensin system (HP:0000841) | 1.73150890 |
| 157 | IgA deficiency (HP:0002720) | 1.72474078 |
| 158 | Keratoconjunctivitis (HP:0001096) | 1.72353222 |
| 159 | Bulbar palsy (HP:0001283) | 1.71986900 |
| 160 | Increased serum ferritin (HP:0003281) | 1.71849235 |
| 161 | Osteomyelitis (HP:0002754) | 1.70174424 |
| 162 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.69919456 |
| 163 | Growth hormone excess (HP:0000845) | 1.69336451 |
| 164 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.69296383 |
| 165 | Progressive neurologic deterioration (HP:0002344) | 1.67638118 |
| 166 | Basal ganglia calcification (HP:0002135) | 1.67636880 |
| 167 | Cerebral hemorrhage (HP:0001342) | 1.67383822 |
| 168 | Partial duplication of thumb phalanx (HP:0009944) | 1.67304862 |
| 169 | Keratoconjunctivitis sicca (HP:0001097) | 1.67296241 |
| 170 | Dysostosis multiplex (HP:0000943) | 1.65901450 |
| 171 | Abnormality of the basal ganglia (HP:0002134) | 1.65757468 |
| 172 | Joint hemorrhage (HP:0005261) | 1.65729311 |
| 173 | Abnormality of the nasal mucosa (HP:0000433) | 1.65441584 |
| 174 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.65403012 |
| 175 | Abnormal tarsal ossification (HP:0008369) | 1.64238700 |
| 176 | Joint swelling (HP:0001386) | 1.63756692 |
| 177 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.62533841 |
| 178 | Subaortic stenosis (HP:0001682) | 1.62533841 |
| 179 | Scapular winging (HP:0003691) | 1.61586617 |
| 180 | Esophageal varix (HP:0002040) | 1.61168715 |
| 181 | Ridged nail (HP:0001807) | 1.60597056 |
| 182 | Calcaneovalgus deformity (HP:0001848) | 1.59945107 |
| 183 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.59932584 |
| 184 | Acanthosis nigricans (HP:0000956) | 1.59300617 |
| 185 | Eosinophilia (HP:0001880) | 1.58207783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 5.81937266 |
| 2 | TIE1 | 4.95145199 |
| 3 | MAPK15 | 3.55573846 |
| 4 | GRK7 | 3.12396862 |
| 5 | INSRR | 3.02598597 |
| 6 | ACVR1B | 2.60862958 |
| 7 | MAP4K2 | 2.40651559 |
| 8 | TAOK3 | 2.30163567 |
| 9 | STK10 | 2.23273517 |
| 10 | EIF2AK3 | 2.01799686 |
| 11 | OBSCN | 2.00517031 |
| 12 | MST4 | 1.95002564 |
| 13 | RIPK4 | 1.91504510 |
| 14 | KDR | 1.87811830 |
| 15 | WNK3 | 1.79606319 |
| 16 | TYK2 | 1.76823237 |
| 17 | TRPM7 | 1.73762663 |
| 18 | MAPK12 | 1.69165884 |
| 19 | GRK1 | 1.64422542 |
| 20 | NME1 | 1.60453852 |
| 21 | MST1R | 1.60109789 |
| 22 | KIT | 1.58560977 |
| 23 | PDK2 | 1.56999929 |
| 24 | SYK | 1.55241005 |
| 25 | TEC | 1.52530267 |
| 26 | IRAK4 | 1.51810654 |
| 27 | FGR | 1.48017842 |
| 28 | ITK | 1.43762059 |
| 29 | TXK | 1.42081526 |
| 30 | MAP3K3 | 1.41881308 |
| 31 | IRAK3 | 1.41427900 |
| 32 | NEK9 | 1.39868216 |
| 33 | PHKG1 | 1.37116320 |
| 34 | PHKG2 | 1.37116320 |
| 35 | MATK | 1.33165777 |
| 36 | CAMK1D | 1.32501611 |
| 37 | DAPK2 | 1.32270494 |
| 38 | EPHB1 | 1.31046598 |
| 39 | PRKG2 | 1.28971007 |
| 40 | NLK | 1.27998814 |
| 41 | PIK3CG | 1.27076611 |
| 42 | CSK | 1.20089400 |
| 43 | TBK1 | 1.16619918 |
| 44 | PRKAA2 | 1.15118487 |
| 45 | MAP2K3 | 1.14988089 |
| 46 | IKBKE | 1.12903232 |
| 47 | TTN | 1.12556737 |
| 48 | PIK3CA | 1.12168332 |
| 49 | STK39 | 1.11703075 |
| 50 | ZAP70 | 1.11194110 |
| 51 | MAP2K6 | 1.11107311 |
| 52 | JAK1 | 1.07732941 |
| 53 | MAP2K2 | 1.07398805 |
| 54 | TNIK | 1.05318527 |
| 55 | WNK4 | 1.04885455 |
| 56 | DMPK | 1.03129366 |
| 57 | ERBB3 | 1.02415800 |
| 58 | MARK3 | 1.01348468 |
| 59 | CDK8 | 1.01282055 |
| 60 | MAP4K1 | 1.00669860 |
| 61 | TGFBR1 | 0.99866834 |
| 62 | CAMKK2 | 0.99351180 |
| 63 | FLT3 | 0.99020599 |
| 64 | CAMK1G | 0.97172464 |
| 65 | TNK2 | 0.96028120 |
| 66 | VRK1 | 0.93354281 |
| 67 | CDK9 | 0.93097980 |
| 68 | CDK3 | 0.92722191 |
| 69 | PAK4 | 0.92151640 |
| 70 | MAP3K12 | 0.87745195 |
| 71 | MAPK7 | 0.87239712 |
| 72 | FGFR3 | 0.86987016 |
| 73 | MAP3K5 | 0.83221389 |
| 74 | STK38L | 0.81147038 |
| 75 | PAK3 | 0.80724532 |
| 76 | CSF1R | 0.77571583 |
| 77 | IKBKB | 0.76706307 |
| 78 | MAPKAPK5 | 0.75452446 |
| 79 | IRAK2 | 0.74250757 |
| 80 | TSSK6 | 0.72761583 |
| 81 | ADRBK2 | 0.72346313 |
| 82 | CSNK1G2 | 0.71045441 |
| 83 | MYLK | 0.70085763 |
| 84 | LCK | 0.69157393 |
| 85 | STK3 | 0.68993447 |
| 86 | JAK3 | 0.68264118 |
| 87 | MOS | 0.68259355 |
| 88 | PDK1 | 0.67546012 |
| 89 | STK24 | 0.66534572 |
| 90 | MUSK | 0.66004934 |
| 91 | PINK1 | 0.64529116 |
| 92 | PLK2 | 0.63775666 |
| 93 | IGF1R | 0.63762933 |
| 94 | MAP3K14 | 0.62365765 |
| 95 | BMPR1B | 0.61634403 |
| 96 | CSNK1A1L | 0.60436071 |
| 97 | EPHB2 | 0.60040170 |
| 98 | MAPKAPK2 | 0.60006118 |
| 99 | FRK | 0.59791165 |
| 100 | NUAK1 | 0.59430298 |
| 101 | NEK6 | 0.58481417 |
| 102 | GSK3A | 0.58421212 |
| 103 | BCKDK | 0.58161731 |
| 104 | ABL1 | 0.56595181 |
| 105 | JAK2 | 0.56290501 |
| 106 | PRKCE | 0.55339339 |
| 107 | LYN | 0.54962627 |
| 108 | CSNK1G3 | 0.54874579 |
| 109 | OXSR1 | 0.54507410 |
| 110 | MAP3K2 | 0.53720267 |
| 111 | ZAK | 0.53656968 |
| 112 | CLK1 | 0.53332155 |
| 113 | BTK | 0.52603305 |
| 114 | CHUK | 0.51543482 |
| 115 | HCK | 0.50767228 |
| 116 | MAP3K11 | 0.50593528 |
| 117 | LRRK2 | 0.50332678 |
| 118 | BMPR2 | 0.49256059 |
| 119 | EIF2AK2 | 0.48803890 |
| 120 | BLK | 0.48744806 |
| 121 | MET | 0.48580560 |
| 122 | MAPK13 | 0.47996380 |
| 123 | ABL2 | 0.47768726 |
| 124 | FES | 0.45839778 |
| 125 | MAP3K1 | 0.43038505 |
| 126 | PRKG1 | 0.42148229 |
| 127 | MAPKAPK3 | 0.40635473 |
| 128 | MKNK2 | 0.40129494 |
| 129 | ADRBK1 | 0.39258456 |
| 130 | PKN1 | 0.38908774 |
| 131 | YES1 | 0.38353768 |
| 132 | LMTK2 | 0.38310299 |
| 133 | PTK2B | 0.36066078 |
| 134 | MAPK4 | 0.35894863 |
| 135 | PRKD1 | 0.35289855 |
| 136 | IRAK1 | 0.35037699 |
| 137 | PTK6 | 0.34408833 |
| 138 | PIM1 | 0.34229674 |
| 139 | INSR | 0.33566232 |
| 140 | PRKCQ | 0.32450866 |
| 141 | SGK2 | 0.32246069 |
| 142 | FER | 0.29989448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 3.18248355 |
| 2 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.58425689 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.36480203 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19549260 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14674828 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.06362990 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.02100365 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.98312358 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.92622731 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.92516912 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.85311232 |
| 12 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.84956806 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.79617740 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.75058205 |
| 15 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.70610819 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.69037090 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.66016166 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65059698 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59823927 |
| 20 | Mineral absorption_Homo sapiens_hsa04978 | 1.58067206 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.57828754 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.57637899 |
| 23 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.52522136 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.52441613 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.49943319 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47573108 |
| 27 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.43500199 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41356421 |
| 29 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.41096113 |
| 30 | Adherens junction_Homo sapiens_hsa04520 | 1.40363726 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.39061273 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36658734 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.35398378 |
| 34 | Platelet activation_Homo sapiens_hsa04611 | 1.34747242 |
| 35 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.33475115 |
| 36 | Measles_Homo sapiens_hsa05162 | 1.29249294 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.25134383 |
| 38 | Focal adhesion_Homo sapiens_hsa04510 | 1.24691987 |
| 39 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.22722750 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.20725919 |
| 41 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.19037289 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.18238765 |
| 43 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.16719565 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15895331 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15812746 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14881336 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.10943968 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.09219796 |
| 49 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.09083347 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08103701 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.07463152 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.06889705 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 1.05578764 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04423743 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.04203607 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.03773653 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02762818 |
| 58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.01952289 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.01620428 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00970499 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99206543 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.97413677 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.96402875 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94687308 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.94285383 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93611704 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 0.93520569 |
| 68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.89278987 |
| 69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87764310 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.87577990 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.87237148 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.87070100 |
| 73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86795790 |
| 74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.85228936 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83392084 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83352943 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82332305 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81907712 |
| 79 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80682835 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.80370081 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79768717 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79735503 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78266569 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77340377 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76979636 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.75551346 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.75334980 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74547193 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.72393770 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72006150 |
| 91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72004199 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71313275 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69795743 |
| 94 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.69720453 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69697487 |
| 96 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69671105 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68959815 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68803521 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.68665364 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68413976 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68264197 |
| 102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66644125 |
| 103 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66158706 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65825188 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.65811063 |
| 106 | Protein export_Homo sapiens_hsa03060 | 0.64425403 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63826210 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.63588014 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63046016 |
| 110 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61980639 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61881637 |
| 112 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.61466601 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | 0.61310410 |
| 114 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60184862 |
| 115 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.60008259 |
| 116 | Renin secretion_Homo sapiens_hsa04924 | 0.59983269 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.58125715 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57674705 |
| 119 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56355504 |
| 120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55022074 |
| 121 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54550731 |
| 122 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54353520 |
| 123 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54183899 |
| 124 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53361262 |
| 125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52344351 |
| 126 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52114140 |
| 127 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51309464 |
| 128 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50745350 |
| 129 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50741518 |
| 130 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50667750 |
| 131 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50192667 |
| 132 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48501539 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48311914 |
| 134 | Shigellosis_Homo sapiens_hsa05131 | 0.48160206 |
| 135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47069096 |
| 136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46860214 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40639976 |
| 138 | Salivary secretion_Homo sapiens_hsa04970 | 0.39401907 |
| 139 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.38194271 |
| 140 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.38109515 |
| 141 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36103470 |
| 142 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35230141 |
| 143 | Phototransduction_Homo sapiens_hsa04744 | 0.33728865 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32430326 |

